HYBRID EVENT:You can Participate either IN-PERSON or virtually through ZOOM from your home/work.
8th World Congress on
CANCER RESEARCH AND THERAPY
Jul 19 - 20, 2023 at Frankfurt, Germany (Hybrid Event)
HYBRID EVENT:You can Participate either IN-PERSON or virtually through ZOOM from your home/work.
After the grand success of previous cancer conference, we solicit your gracious presence at the “8th World Congress on CANCER RESEARCH AND THERAPY" (WCCRT-2023) which will be conducted during July 19-20,2023 as a hybrid event at Frankfurt, Germany and virtually. The conference will emphasize the theme “Novel Discoveries in Cancer Research & Treatment”.
Cancer Congress 2023 is now opening a call for sessions, aiming to develop a programme that brings together the very best of innovation and progress happening across the full spectrum of cancer control, at national, regional and global levels.This is a unique opportunity for cancer experts to share their knowledge and experience with the global cancer community, gain visibility and contribute to advancing cancer control.
A special invitation is extended to international colleagues to attend and contribute to the conference.
The important benefits of attending this conference includes:
Mark your calendars now and for more details, please contact us by email @ cancercongress@innovincinternational.com or Tel: +1-408-352-1010
Al-Ahliyya Amman University
Jordan
Osmania University
INDIA
Alfred Böcking
Germany
Swansea University
United Kingdom
shanxi cancer hospital
China
Thomas Vogl
Germany
Warsaw Medical University
Poland
UAB Medicine - Hematology Oncology
USA
Wayne State University, USA
Osmania University, India
University of Wisconsin-Stevens Point, USA
Jazan univeristy, Saudi Arabia
Speclipse, Inc., Korea
Kameda Medical Center, Japan
Sarah Cannon Cancer Center-HCA, USA
West Virginia University Cancer Institute, USA
Al-Ahliyya Amman University, Jordan
Poznan University of Medical Sciences, Poland
DAIICHI SANKYO CO., LTD, Japan
Maharshi Dayanand University, India
Institute of Cytopathology, Germany
The Second Affiliated Hospital of Chongqing Medical University, China
Jaber Al Ahmed Hospital, Kuwait
University of Kentucky College of Medicine, USA
University College Cork, Ireland
University of Rome “Tor Vergata”, Italy
Henan Provincial People’s Hospital/Zhengzhou University , China
Cardiff University, United Kingdom
Japanese Society on Inflammation and Metabolism in Cancerl, Japan
University of Kansas Medical Center, USA
Warsaw Medical University, Poland
Baruch S Blumberg Institute, USA
Shanxi cancer hospital, China
Chongqing General Hospital, China
The Open University, United Kingdom
University of Bydgoszcz, Poland
Swansea University, United Kingdom
Columbia University Medical center, USA
Xiamen Huaxia University, China
Northwell Health Cancer Institute, USA
University of Maryland, Baltimore, USA
Hong Kong University of Science and Technology, China
FUESMEN, Argentina
Otsuka America Pharmaceuticals, USA
Crown Bioscience, Netherlands
Vall d´Hebron Research Institute, Spain
Cardiff University, United Kingdom
Wayne State University School of Medicine, USA
Aalen University, Germany
Rutgers University, USA
Linear Clinical Research, Perth, WA, Australia
University of Innsbruck, Austria
Affiliated Cancer Hospital of Zhengzhou University, China
KAMC-NGHA, Saudi Arabia
University of Nevada, USA
Frankfurt University Hospital, Germany
Sichuan University, China
The Ohio State University, USA
University of Nebraska Medical Center, USA
University of texas Health Science at Houston, USA
University of Texas Health Science Center, USA
Obstetrics and Gynecology Hospital, Fudan University, China
Houston Methodist Research Institute, USA
Nanjing Drum Tower Hospital, China
Tokyo Medical and Dental University, Japan
Toolgen, Korea
University of Milano-Bicocca, Italy
Praxis für Hämatologie und Onkologie, Germany
Johnson & Johnson, USA
Case Western Reserve University, USA
Indiana University School of Medicine, USA
Memorial Sloan Kettering Cancer Center, USA
SBI Pharmaceuticals, Japan
Centre de Recherche en cancérologie de Lyon, France
University of Washington, USA
Beijing Chao-Yang Hospital, China
The Uni. of Texas,M.D.Anderson.org, USA
Cranfield University, United Kingdom
Yale University/ yale Cancer Center, USA
University of Washington, USA
Fukushima Medical University, Japan
All India Institute of Medical Sciences, India
Thomas Jefferson University, USA
Shanghai Jiao Tong University School of Medicine, China
Huazhong University of Science and Technology, China
Beijing Tiantan Hospital, Capital Medical University, China
University of Pavia, Italy
Icahn School of Medicine at Mount Sinai, United States
Northern Arizona University, USA
The Hopi Tribe, USA
Chongqing Hospital of Traditional Chinese Medicine, China
Don t Miss This Amazing Conference And Opportunities
The conference was wonderful and it was a pleasure to present our talk.
I enjoyed speaking at the London Cancer Conference in 2019
It was a pleasure to took attendance in the conference. the speakers and studies were wide profile from different perspectives.